Company news

OPKO Health, Inc. news in 2023

OPKO Health, Inc.'s news releases, calls and decks from 2023, newest first.

View company

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

November 27, 2023

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

November 5, 2023

New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

November 1, 2023

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

October 30, 2023

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

October 24, 2023

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

September 27, 2023

OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results

August 2, 2023

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

July 24, 2023

OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results

May 2, 2023

OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023

April 24, 2023

OPKO Health to Hold Virtual R&D Day on March 20, 2023

March 8, 2023

OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate

March 7, 2023

OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results

February 22, 2023

OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023

February 15, 2023

BioReference Now Offers the Only FDA-Approved Dual-Stain Triage Test to Enhance Cervical Cancer Screenings

February 8, 2023

OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

January 2, 2023

Calls in 2023